MedPath

Feeding Trial in the Obese Critical Care Population

Completed
Conditions
Critical Illness
Obesity
Interventions
Other: enteral formula
Registration Number
NCT01357200
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.

Detailed Description

Assess enteral feeding goal with a higher protein whey based peptide formula in an obese critically ill population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Age ≥ 18 years
  • Surgical or Medical intensive care unit (ICU) patient
  • Body mass index (BMI) ≥ 30
Exclusion Criteria
  • pregnant or lactating
  • unable to access gastrointestinal (GI) tract for feeding via tube
  • other contraindication to tube feeding
  • admitted with burns
  • severe head trauma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
critically ill obese adultsenteral formulaAge ≥ 18 years, body mass index (BMI) ≥ 30, in intensive care unit (ICU) requiring tube feeding ≥ 3 days
Primary Outcome Measures
NameTimeMethod
time to feeding goal achievementup to 5 days

on all participants

Secondary Outcome Measures
NameTimeMethod
gastrointestinal measures assessmentdaily for up to 11 days

on all participants

percent of nutrition goal metup to 5 days

on all participants

assessment of frequency and nature of adverse eventsdaily for up to 11 days

on all participants

serum biochemical markers assessmentdaily for up to 11 days

on all participants

Trial Locations

Locations (2)

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

University of Louisville

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath